Clinical Trials in South Korea / NCT00869817
Recruiting
Observational
Dominantly Inherited Alzheimer Network (DIAN)
NCT00869817 · tracked via the Priya Life Science South Korea tracker
Condition(s) studied
Alzheimer's Disease
Study summary
The purpose of this study is to identify potential biomarkers that may predict the development of Alzheimer's disease in people who carry an Alzheimer's mutation.
Eligibility
Inclusion Criteria:
* Written informed consent obtained from participant and collateral source prior to any study-related procedures.
* Aged 18 (inclusive) or older and the child of an affected individual (clinically or by testing) in a pedigree with a known mutation for ADAD.
* Cognitively normal to very mild or mild cognitive impairment (CDR score range 0-1.0). Primary enrollment will focus on the recruitment of asymptomatic adult children who are more than 15 years younger than the estimated age of symptom onset. Enrollment of new participants with moderate cognitive impairment is allowed with the prior approval of the DIAN Coordinating Center.
* Has two persons who are not their full-blooded siblings who can serve as collateral sources for the study.
* Fluent in a language approved by the DIAN Coordinating Center at about the 6th grade level (international equivalent) or above.
Exclusion Criteria:
* Under age 18
* Medical or psychiatric illness that would interfere in completing initial and follow-up visits
* Requires nursing home level care
* Has no one who can serve as a study informant
Primary outcome measure(s)
- Positive predictive power of a biomarker or group of biomarkers — Variable follow-up assessment based on age in relation to age at onset of affected parent.
- Biomarkers obtained by blood draw, lumbar puncture, MRI, FDG PET, PET amyloid imaging — Variable follow-up assessment based on age in relation to age at onset of affected parent
- Clinical markers also examined from clinical interview and cognitive testing — Variable follow-up assessment based on age in relation to age at onset of affected parent
Trial sites (26)
| Facility | City | Region | Status |
|---|---|---|---|
| Mayo Clinic Jacksonville | Jacksonville | Florida | Recruiting |
| Indiana University-Indiana Alzheimer Disease Center | Indianapolis | Indiana | Recruiting |
| Brigham and Women's Hospital | Boston | Massachusetts | Recruiting |
| Washington University in St. Louis School of Medicine | St Louis | Missouri | Recruiting |
| Columbia University | New York | New York | Suspended |
| University of Pittsburgh | Pittsburgh | Pennsylvania | Recruiting |
| Butler Hospital | Providence | Rhode Island | Recruiting |
| University of Washington | Seattle | Washington | Recruiting |
| Fundación para la Lucha contra las Enfermedades Neurológicas de la Infancia (FLENI) | Salta | Salta Province | Recruiting |
| Fundación para la Lucha contra las Enfermedades Neurológicas de la Infancia" (FLENI) Instituto de Investigaciones Neurológicas Raúl Correa | Buenos Aires | Argentina | Recruiting |
| Neuroscience Research Australia | Sydney | New South Wales | Recruiting |
| Mental Health Research Institute, University of Melbourne | Melbourne | Victoria | Suspended |
| Sir James McCusker Alzheimer's Disease Research Unit, Edith Cowan University | Perth | Western Australia | Recruiting |
| Hospital das Clinicas da Faculdade de Medicina da Universidade de São Paulo | São Paulo | São Paulo | Recruiting |
| McGill University Research Centre for Studies in Aging | Verdun | Quebec | Not Yet Recruiting |
| Grupo Neurociencias de Antioquia | Medellín | Colombia | Recruiting |
| German Center for Neurodegenerative Diseases (DZNE) Munich, and University Hospital Ludwig-Maximilians-Universitat (LMU) Munich | Munich | Germany | Recruiting |
| German Center for Neurodegenerative Diseases (DZNE) Tübingen and Hertie-Institute for Clinical Brain Research, University of Tübingen | Tübingen | Germany | Recruiting |
| Niigata University | Niigata | Japan | Recruiting |
| Osaka City University | Osaka | Japan | Suspended |
| Tokyo University | Tokyo | Japan | Recruiting |
| Instituto Nacional de Neurología y Neurocirugía "Manuel Velasco Suarez" | Mexico City | Mexico City | Recruiting |
| Amsterdam UMC | Amsterdam | Netherlands | Recruiting |
| Asan Medical Center | Seoul | Songpa-Gu | Recruiting |
| Hospital Clinic Barcelona | Barcelona | Catalonia | Suspended |
| Institute of Neurology, Queen Square | London | United Kingdom | Recruiting |
More Washington University School of Medicine trials in South Korea
Other trials for the same condition
Official registry record
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT00869817 on ClinicalTrials.gov ↗ ← All trials in South Korea